Holen Sie sich die Stockscreener-App
5.83
1.52%
-0.09
Schlusskurs vom Vortag:
$5.92
Offen:
$5.96
24-Stunden-Volumen:
19,540
Relative Volume:
0.04
Marktkapitalisierung:
$213.03M
Einnahmen:
$18.81M
Nettoeinkommen (Verlust:
$-38.90M
KGV:
-4.673
EPS:
-1.2476
Netto-Cashflow:
$-38.83M
1W Leistung:
-11.93%
1M Leistung:
-4.43%
6M Leistung:
-14.77%
1J Leistung:
-0.51%
1-Tages-Spanne:
$5.75
$6.0048
1-Wochen-Bereich:
$5.835
$6.74
52-Wochen-Spanne:
$4.80
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Firmenname
Profound Medical Corp
Sektor
Branche
Telefon
647-476-1350
Adresse
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.83 | 213.03M | 18.81M | -38.90M | -38.83M | -1.2476 |
ABT
Abbott Laboratories
|
98.61 | 170.62B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.39 | 119.46B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.48 | 112.95B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.14 | 63.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 50.56B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-27 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-07-23 | Eingeleitet | Lake Street | Buy |
| 2024-07-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-11-28 | Eingeleitet | Stifel | Hold |
| 2023-08-04 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-15 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Profound Medical Corp Aktie (PROF) Neueste Nachrichten
Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect? - Zacks Investment Research
A prostate treatment passed technical tests on a less powerful MRI machine; patient use there is unproven. - Stock Titan
Can Profound Medical’s (TSX:PRN) Telix Pact Expand TULSA-PRO’s Reach? - Kalkine Media
First U.S. Brain Scan Doses Could Be A Game Changer For Telix Pharmaceuticals (ASX:TLX) - Simply Wall Street
Profound Medical Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Marjorie Taylor Greene Stock Trades and Disclosures - TechGraph
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
Physician webinars are planned under Profound Medical (PROF) and Telix’s prostate care education pact. - Stock Titan
Profound, Telix Partner, Shares Up - Baystreet.ca
The companies plan to teach doctors how prostate scans complement MRI-guided treatment. - Stock Titan
Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? - Zacks Investment Research
Pacira BioSciences jumps 44% after Viatris agre... - Pluang
Raymond James reiterates Strong Buy on Profound Medical stock, $11 target - Investing.com Canada
Why is Profound Medical stock surging today? - Investing.com
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue - Investing News Network
Profound Medical (PROF) Projects Over 70% Gross Margin in Q3, Si - GuruFocus
Profound Medical stock surges 20% on raised Q3 revenue outlook - Investing.com
Small caps to watch: Earnings beats and misses, a dividend hike alongside a special payout, and more - The Globe and Mail
Profound Medical Reports Preliminary Q3 Revenue Above Street View; Shares Rise After-Hours - marketscreener.com
What's going on in today's after hours session - ChartMill
Gross margin is expected to top 70% as Profound Medical (PROF) previews preliminary Q3 revenue. - Stock Titan
Profound Medical Corp. Provides Earnings Guidance for the Third Quarter Ended September 30, 2026 - www.marketscreener.com
NN won about $130 million in annual new business over 12 months. The deal is expected to bring in about $50 million. - Stock Titan
Profound Medical And 2 Other Canadian AI Healthcare Stocks To Watch - Simply Wall Street
The businesses behind the Knicks and Rangers are expected to split into two companies Oct. 26. - Stock Titan
President of Profound Medical Richard Fabian Buys More Stock - simplywall.st
President of Profound Medical Richard Fabian Buys More Stock - simplywall.st
Profound Medical (TSX:PRN) Slides 11.92% as Bearish Pressure Builds: Can TULSA-PRO Momentum Offset Near-Term Weakness? - kalkine.ca
Profound Medical Stock Drops 11.92% as Investor Caution Builds Around Growth, Execution and Valuation - kalkine.ca
Why Profound Medical Corp stock plummeted yesterday - Wealth Awesome
(PRN) Strategic Equity Report (PRN:CA) - Stock Traders Daily
What's Going On With Profound Medical Corp Stock Monday? - Wealth Awesome
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch - Yahoo Finance
Profound Medical to Present at BIG10 Growth Conference - TipRanks
Profound Medical (NASDAQ: PROF) plans one-on-one investor talks at BIG10 conference - Stock Titan
Profound Medical Corp. (PROF) Peer Comparison – Compare with Others - Value Research
Profound Medical to Participate in Lake Street's 10th Annual Best Ideas Growth Conference - Investing News Network
Profound Medical Corp. to Present at Lake Street Capital Markets BIG10 Conference on September 10 - kalkine.ca
Profound Medical Names Richard Fabian as New President - TipRanks
Profound Medical names Richard R. Fabian as President; Mathieu Burtnyk becomes CTO - TradingView
New Profound Medical (PROF) president set for $550,000 salary plus stock awards - Stock Titan
A medical device company will meet investors in New York. No webcast will be available. - Stock Titan
(PROF) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Profound Medical names Richard Fabian as president By Investing.com - Investing.com Australia
Profound Medical names Richard Fabian as president By Investing.com - Investing.com Nigeria
Profound Medical Appoints Richard Fabian as President - marketscreener.com
Profound Medical Taps Industry Veteran Richard Fabian as President in Leadership Realignment - tipranks.com
Profound Medical Names Industry Veteran Richard Fabian as President in Leadership Realignment - TipRanks
Profound Medical Appoints Richard Fabian President - marketscreener.com
Profound Medical names Richard Fabian as president By Investing.com - Investing.com India
Finanzdaten der Profound Medical Corp-Aktie (PROF)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
1.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):